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http:WHAT THIS PAPER ADDS
The failure of arteriovenous ﬁstulas (AVFs) to mature remains a signiﬁcant problem for patients who require
chronic hemodialysis. However, the mechanisms underlying this phenomenon are poorly understood. A key
vascular component in this remodeling process is elastin, an extracellular matrix component that is essential for
the mechanical property of a blood vessel. It is shown that a reduced capacity to synthesize elastin improves
outward remodeling in AVFs, suggesting that targeted reduction of elastin could be an effective modality in
enhancing AVF patency.Objectives: Maturation failure is the major limitation of arteriovenous ﬁstulas (AVFs) as hemodialysis access
conduits. Indeed, 30e50% of AVFs fail to mature due to intimal hyperplasia and insufﬁcient outward remodeling.
Elastin has emerged as an important determinant of vascular remodeling. Here the role of elastin in AVF
remodeling in elastin haplodeﬁcient (elnþ/e) mice undergoing AVF surgery has been studied.
Methods: Unilateral AVFs between the branch of the jugular vein and carotid artery in an end to side manner
were created in wild-type (WT) C57BL/6 (n ¼ 11) and in elnþ/e mice (n ¼ 9). Animals were killed at day 21 and
the AVFs were analyzed histologically and at an mRNA level using real-time quantitative polymerase chain
reaction.
Results: Before AVF surgery, a marked reduction in elastin density in the internal elastic lamina (IEL) of elnþ/e
mice was observed. AVF surgery resulted in fragmentation of the venous internal elastic lamina in both groups
while the expression of the tropoelastin mRNA was 53% lower in the elnþ/e mice than in WT mice (p < .001). At
21 days after AVF surgery, the circumference of the venous outﬂow tract of the AVF was 21% larger in the elnþ/e
mice than in the WT mice (p ¼ .037), indicating enhanced outward remodeling in the elnþ/e mice. No signiﬁcant
difference in intimal hyperplasia was observed. The venous lumen of the AVF in the elnþ/e mice was 53% larger
than in the WTmice, although this difference was not statistically signiﬁcant (elnþ/e, 350,116  45,073 mm2; WT,
229,405  40,453 mm2; p ¼ .064).
Conclusions: In a murine model, elastin has an important role in vascular remodeling following AVF creation, in
which a lower amount of elastin results in enhanced outward remodeling. Interventions targeting elastin
degradation might be a viable option in order to improve AVF maturation.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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An adequate functioning arteriovenous ﬁstula (AVF) is the
preferred mode of vascular access for patients requiring
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//dx.doi.org/10.1016/j.ejvs.2014.12.035cannulation of the venous outﬂow tract. Unfortunately, 30e
50% of ﬁstulae fail to mature,1 eventually leading to a poor
1 year primary patency of 60e65%.2,3 The pathophysiology
responsible for inadequate maturation is incompletely
understood.
AVF maturation results from a cascade of processes after
AVF surgery, that lead to the reorganization of the extra-
cellular matrix (ECM).4 This matrix metalloproteinase
(MMP) mediated process of vascular remodeling allows the
vessels of the ﬁstula to enlarge. The main ECM components
that are involved in this outward remodeling are collagen
and elastin. In vascular physiology, elastic ﬁbers provide the
vessel its elasticity and resilience, thereby providing the
Outward Remodeling in Arteriovenous Fistulas 481ability to absorb hemodynamic stress.5,6 Elastin is a cross
linked, insoluble polymer of the monomeric secreted form
of the protein tropoelastin that is secreted primarily by
vascular smooth muscle cells (VSMCs) and diverse ﬁbro-
blasts.6,7 Elastin homeostasis has emerged as an important
determinant of vascular outward remodeling. Indeed,
elastic ﬁber degradation mediates physiological outward
remodeling as occurs in the uterine artery during preg-
nancy.8,9 Additional support for a role of elastin degradation
in outward remodeling comes from studies in patients with
aortic aneurysms, showing that polymorphisms in the
elastin gene10 may contribute to the pathogenesis of this
pathological arterial dilation. In the present study, it was
hypothesized that elastin might be an important regulator
in outward remodeling in AVF. For this purpose, end to side
AVFs were created in haplodeﬁcient tropoelastin knockout
mice.5
MATERIAL AND METHODS
Animals and study design
The Institutional Committee for Animal Welfare at the
LUMC approved all experiments. Adult male C57BL/6 (WT)
(Charles River) and elnþ/e mice with a C57BL/6 background
aged 10e17 weeks (weighing 23e35 g) were used for the
experiments and received unilateral AVFs. The animals were
killed on day 21 following the surgical procedure. Identical
veins of unoperated mice were used to assess elastic ﬁber
density before surgery.
Surgical procedure
An unilateral AVF was created as previously described11
(Fig. 1A). In short, the animal was anesthetized using iso-
ﬂurane followed by shaving and disinfection of the skin in
the ventral neck area and ﬁxed in a supine position on a
heating blanket. The mouse was then injected withFigure 1. Surgical scheme and orientation of sectioning. (A) Schema
anastomosis between the common carotid artery (a) and the dorso
interrupted sutures. (B) Schematic overview of sectioning locations wit
a sectioning area with a ﬁxed interval of approximately 150 mm.buprenorphin (0.1 mg/kg) (MSD, Whitehouse Station, NJ,
USA) and 0.5 mL of saline. Under a dissecting microscope
(M80, Leica, Wetzlar, Germany) an incision in the ventral
midline of the neck area was made, followed by a dissection
of the right dorsomedial branch of the external jugular vein
and ipsilateral common carotid artery after the excision of
the sternocleidomastoid muscle using a heat cauterizer.
Next, after applying a vascular clamp (S&T, Neuhausen,
Switzerland) to the proximal and distal artery an approxi-
mately 1 mm incision was made using a microscissor (Fine
Science Tools, Heidelberg, Germany) and the lumen was
rinsed with a heparin solution (100 IU/mL) (LEO Pharma,
Ballerup, Denmark). The vein was then clamped proximally
and ligated distally, followed by a transection just proximal
to the ligation. After rinsing the vein with a heparin solu-
tion, an end to side anastomosis was created using 10.0
interrupted sutures (Braun, Melsungen, Germany). Halfway
through the suturing procedure heparin was injected
intravenously at a dose of 0.2 IU/g bodyweight. After
completion of the anastomosis, the remaining clamps were
removed and patency was assessed. The skin was closed
with a 6.0 running suture (Braun, Melsungen, Germany).
Following completion of the surgery 0.5 mL of saline was
injected subcutaneously and the animals were kept warm
until recovery.
Tissue harvesting and processing
Animals received an intraperitoneal injection with an
anesthetic mixture containing midazolam (5 mg/kg)
(Roche, Basel, Switzerland), medetomidine (0.5 mg/kg)
(Orion, Espoo, Finland), and fentanyl (0.05 mg/kg) (Jans-
sen, High Wycombe, UK) whereupon a re-incision was
made over the scar. The AVF, including its venous and
arterial limb, was dissected and the patency was assessed
clinically. For this purpose, the blood ﬂow was disrupted
by compressing the distal arterial as well as the distaltic visualization of an arterial side to venous end arteriovenous
medial distal branch of the external jugular vein (v) using 10.0
hin the arteriovenous ﬁstula, in which every dashed line represents
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patent when the venous limb proximal to the forceps ex-
pands in diameter. If this phenomenon was not clearly
visible, the AVF was considered not patent. Next, a tho-
racotomy was performed and the inferior vena cava was
transected followed by an intracardiac infusion of phos-
phate buffered saline and formalin 4% at a pressure of
approximately 100 mmHg. The small size of the murine
vasculature and the conﬁguration of the AVF preclude
simultaneous perpendicular analysis of the artery and the
vein. Since most of the stenotic lesions in human AVFs
occur in the venous outﬂow tract, analysis was focused on
the vein (Fig. 1B). The tissue was processed in parafﬁn and
sections of 5 mm were made perpendicular to the vein at
12 locations with an interval of 150 mm. For the purpose of
RNA isolation, 20 mm thick sections were obtained from
additional animals.
RNA isolation and real-time quantitative polymerase chain
reaction
Twenty parafﬁn embedded sections, 20 mm thick, repre-
senting the entire AVF were freshly collected and RNA was
isolated from the tissue using RNeasy FFPE Kit (Qiagen,
Gaitherburg, MD, USA). RNA concentration, purity, and
integrity were examined using nanodrop (Nanodrop Tech-
nologies). Relative quantitative mRNA polymerase chain
reaction (PCR) was performed on reverse transcribed cDNA
(High Capacity RNA-to-cDNA kit, Applied Biosystems, art.
no. 4387406) using primers against mouse eln
(Mm00514670_m1, Life technologies, Grand Island, NY,
USA). Quantitative PCRs were run on a 7900HT Fast real-
time PCR system (Applied Biosystems). Normalization of
data was performed using stably expressed endogenous
controls (HPRT).
Spectral microscopy
To study the dispersion of elastic ﬁbers in more detail,
sections stained with Weigert’s elastin were analyzed using
a multispectral imaging system comprising a ﬂuorescent
microscope (DM4000B, Leica, Wetzlar) and a Nuance im-
aging unit (N-MSI-FX, PerkinElmer, Boston, MA, USA). In
short, the speciﬁc spectrum of elastin was selected using
the elastic lamellae present in the carotid artery. This tissue
speciﬁc selection was then located in the venous outﬂow
tract of the AVF and assigned the color red. The background
was assigned the color green.
Morphometric analysis
Histochemical staining with hematoxylin, phloxin, and
saffron (HPS) was used for a morphological overview. After
digitalization of all the venous sections with a microscope
(Carl Zeiss, Oberkochen, Germany), morphometric analysis
was performed on Weigert’s elastin stained sections using
quantitative imaging software (Qwin, Leica, Wetzlar, Ger-
many). The intimal area was calculated by subtracting the
luminal area from the area within the internal elastic lamina
(IEL). The circumference of the vessel was determined bymeasuring the length of the IEL. Results are expressed as
mean  standard error of the mean.Alpha smooth muscle actin staining and quantiﬁcation
All sections were stained against a-smooth muscle actin (a-
sma) to identify vascular smooth muscle cells (VSMCs) and
myoﬁbroblasts using a dilution of 1:1000 for the primary
antibody (Dako, Glostrup, Denmark). Subsequently, the
slides were digitized at a resolution of 2080  1542 pixels
by a camera connected to a microscope (Carl Zeiss, Ober-
kochen, Germany). A detailed protocol of the staining is
listed in the appendix. The a-sma positive area in the total
vessel was measured using quantitative imaging software
(ImageJ) and was expressed in mm2.
Collagen quantiﬁcation
In order to quantify the collagen content in the vessels, the
tissue sections were ﬁrst stained using picro-sirius red and
followed by digitalization using the method as described
above. Using ImageJ software, the collagen content in all
the venous sections was determined by selecting the stain
speciﬁc color for collagen at a ﬁxed average threshold,11
and was expressed in mm2. In order to obtain qualitative
information about the deposition pattern of collagen addi-
tional images were produced using digital image microscopy
with circularly polarized light (Olympus, Shinjuku-ku, Tokyo,
Japan.).Statistical analysis
All data except the patency outcome were expressed as
mean  standard error of the mean. The Fisher exact test
was used for the data on AVF patency. For the histo-
morphometric and real-time quantitative PCR results an
unpaired t test was used. The results from the a-sma
quantiﬁcation were tested using the ManneWhitney U test.
A p value < 0.05 was considered statistically signiﬁcant.
RESULTS
Surgical outcome
Twenty animals (11 WT mice and 9 elnþ/e mice) success-
fully received an AVF, of which two (18%) from the WT
group and one (11%) from the elnþ/e group were occluded
21 days after surgery (p ¼ 1.0). No difﬁculties were
encountered during the surgical procedure in the elnþ/e
mice. The occluded AVFs were excluded from morphometric
analysis, resulting in nine WT mice and eight elnþ/e mice
being included in the study.Elastin expression
At the mRNA level, a relative reduction of 53% in expression
of the mELN gene in elnþ/e mice was observed compared
with the WT mice (1.0  0.19 vs. 0.47  0.07, p < .001)
(Fig. 2A). Using spectral microscopy, a reduction in elastin
accumulation was observed in the IEL of elnþ/e mice before
AVF placement, resulting in a more fragmented IEL
Figure 2. The presence of elastin in the venous outﬂow tract prior to, and after arteriovenous ﬁstula creation. (A) Relative mRNA expression
of murine elastin in the AVF at day 21 after surgery. (BeE) Visualization of elastin (red) (white arrow) in the venous outﬂow tract before
(control) and after surgery (day 21) using spectral microscopy. Note. Original magniﬁcation 100. Scale bar, 50 mm; L ¼ Lumen; þ/
þ ¼ wild type; þ/ ¼ haplodeﬁcient. *p < .05.
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tion, elastin content in the vessel wall was greatly frag-
mented and diminished in both the WT (n ¼ 5) and elnþ/e
mice (n ¼ 6), retaining the pre-existing difference in elastin
content favoring the WT group.Morphometric analysis
Twenty-one days after AVF placement, the circumference in
elnþ/e mice (2936  191 mm) was 21% larger than the WT
mice (2424  126 mm; p ¼ .037), whereas the intimal area
was similar among the groups (WT 112,908  16,029 mm2
vs. elnþ/e 134,967  24,673 mm2; p ¼ .45). The luminal
area of the venous outﬂow tract in the elnþ/e mice was
53% larger than the WT mice, although this difference was
borderline signiﬁcant (elnþ/e 35,0116  45,073 mm2; WT
229,405  40,453 mm2; p ¼ .064) (Fig. 3AeF).Alpha smooth muscle actin
Although the amount of intimal hyperplasia was equal in
both groups after 21 days, a 2.4 fold larger area of a-sma
positive cells was observed in the venous outﬂow tract of
the haplodeﬁcient mice than in the WT
(132169  30725 mm2 vs. 55331  8053 mm2; p ¼ .036)
(Fig. 4AeC).Collagen
At day 21, the amount of collagen observed in the elnþ/e
mice (129,539  19,246 mm2) was 87% greater than the WT
mice (69,180  11,574 mm2, p ¼ .015) (Fig. 4DeF). The
pico-sirius red stained sections, analyzed with circularly
polarized light, revealed that collagen types I and III were
mainly located in the media and adventitia, with limited
collagen content in the intima.DISCUSSION
In the present study the effect of elastin deﬁciency on
venous remodeling in a murine model of AVF failure was
investigated. It was observed that elnþ/e mice have a lower
density of elastic ﬁbers present in the venous IEL prior to
AVF creation than WTmice. After AVF creation, elnþ/e mice
showed an accelerated venous outward remodeling
response while no effect was observed on intimal hyper-
plasia. This adaptive response in the elnþ/e mice resulted in
a trend towards a larger luminal area of the venous outﬂow
tract than in the WT mice.The role of elastin in outward remodeling after
arteriovenous ﬁstula creation
The main objective of AVF surgery in hemodialysis patients
is to create a high ﬂow vascular circuit with a sufﬁcient
venous intraluminal diameter to allow safe cannulation.
According to the Kidney Disease Outcomes Quality Initia-
tive guidelines, AVF maturation is considered clinically
successful, if 6 weeks after surgery the ﬁstula supports a
ﬂow of 600 mL/min, is located at a maximum of 6 mm
from the skin surface, and has a diameter of > 6 mm.12 In
order to achieve the latter, adequate outward remodeling
of the venous outﬂow tract is required. The data from the
present study in which enlarged outward remodeling in
the elastin haplodeﬁcient mice was observed, provide
support for the hypothesis that low elastin content in the
venous outﬂow tract might facilitate AVF maturation. In
addition, reduced elastin expression in the carotid artery
might also have contributed to the increase in venous
outward remodeling, since increased arterial outward
remodeling could stimulate ﬂow induced venous remod-
eling. Unfortunately, the end to side conﬁguration of the
AVF precluded morphometric analysis of cross sections of
the arterial segment. Since intimal hyperplastic lesions in
Figure 3. Morphometric parameters 21 days after AVF creation. (A,B) Hematoxylin, phloxin, and saffron staining (HPS). (C,D) Weigert’s
elastin staining used for the histomorphometric analysis in which the internal elastic lamina (IEL) is highlighted (dashed line). (E,F) His-
tomorphometric data after AVF creation. (G) Mean circumference displayed per individual animal. Original magniﬁcation 100. Scale bar,
200 mm. IH ¼ intimal hyperplasia. * p < .05.
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segment was chosen by cross sectioning the venous part.
Previous clinical studies have also suggested that elastin
degradation might be beneﬁcial for AVF maturation by
showing that patients with matured AVFs have higher
circulating levels of MMP-2 (an elastinolytic protease) than
those with maturation failure.13 A similar association has
been observed between high MMP-2 expression in venous
segments of AVFs and maturation of these ﬁstulas.14
Conversely, peri-adventitial application of recombinant
elastase has been shown to stimulate outward remodeling
in rabbit AVF.15 Interestingly, this approach has recently
been investigated in a phase II clinical trial that revealed
increased maturation of radiocephalic ﬁstulas that were
treated with 30 mg of elastase.16
The role of collagen in AVF adaptation is more complex
since MMPs are not only involved in collagen degradation
but also induce collagen synthesis.17 The higher amount of
total collagen observed in the elnþ/emice corresponds with
their larger vessel wall than the WT mice. Indeed, newly
synthesized collagen ﬁbers are required in order to keeppace with the growing dimensions of the venous vessel
wall. Most likely, VSMCs are the major source of collagen
since during vascular remodelling, proliferating VSMCs
synthesize large amounts of collagen.18
Intimal hyperplasia in elastin haplodeﬁcient mice
In this study, a signiﬁcant difference in intimal hyperplasia
between the elnþ/e and WT mice 21 days after surgery was
not observed. Obviously, increased intimal hyperplasia might
be the downside of impaired elastin synthesis since elastin is
an important inhibitor of VSMC migration and prolifera-
tion,19e21 one of the main mechanisms underlying the
development of intimal hyperplasia.22 The importance of
elastin in vascular function and integrity becomes clear, as
homozygous knockout mice are not viable due to the for-
mation of occlusive arterial lesions consisting of VSMCs.23 In
accordance, increased activity ofMMP-2 andMMP-9 has also
been associated with intimal hyperplasia in arteriovenous
conduits.24e26 In previous studies in the murine AVF model,
progressive growth of intimal hyperplastic lesions up to 4
weeks after surgery was observed.11 In view of the inhibitory
Figure 4. Alpha smooth muscle actin and picro-sirius red staining. (A,B) Immunohistochemical staining using antibodies against a-sma. (C)
Quantiﬁcation of a-sma positive area in the venous outﬂow tract. (D,E) Picro-sirius red staining visualized using circular polarized light
microscopy. (Original magniﬁcation 40). (F) Quantiﬁcation of collagen positive area using the picro-sirius red staining. Original magni-
ﬁcation 100. Scale bar, 200 mm. * p < 0.05.
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that elastin deﬁciency might result in enhanced intimal hy-
perplasia at later time points after surgery.
Interestingly, Franano and co-workers27 observed an 84%
reduction in intimal area in the outﬂow vein of a rabbit AVF
after peri-vascular application of porcine elastase. This
beneﬁcial effect on intimal hyperplasia is most likely driven
by the peri-vascular delivery method of elastase, resulting in
a directional VSMC proliferation and migration to the
adventitia rather than the intima.28,29 This location speciﬁc
elastolytic process, however, was absent in the model used
as only the effect of impaired elastin synthesis, that does
not speciﬁcally target the adventitia, was studied.
While the size of the intimal area did not differ between
the WT elnþ/e mice, a larger content of a-sma positive cells
in the venous outﬂow tract of the elnþ/e mice was
observed. This results from a higher density of a-sma pos-
itive cells in the intima. In addition, the enhanced outward
remodeling response in elnþ/e mice also resulted in larger
VSMC content in the adventitia and media. This observation
supports the hypothesis that VSMC proliferation in the
initial phase after AVF surgery is required in order to keep
pace with the expansion of the venous outﬂow tract, as
demonstrated previously in ﬂow induced arterial outward
remodeling in rats.30Study limitations
The uremic milieu has a clear impact on the progression of
vascular diseases in end-stage renal disease patients.
Recent studies have suggested that uremic conditions also
contribute to the formation of intimal hyperplasia in veins
prior to AVF surgery.31,32 In order to further elucidate the
mechanisms involved in AVF maturation, incorporation of
chronic renal failure33 would be of added value.Another limitation of the experiments is the absence of
data on ﬂow measurements, since a high blood ﬂow is one
of the main characteristics of a functional AVF for hemo-
dialysis access. For technical reasons, quantiﬁcation of
blood ﬂow using ultrasonography or magnetic resonance
imaging was not successful in this study.
Although murine models are useful to study of the
pathophysiology of human diseases, one should remain
cautious in the extrapolation of these results to the human
setting because the pathology in animals does not neces-
sarily mimic the pathology in humans.
Finally, it should be taken into account that the homozy-
gous elne/e mouse could not be incorporated into our AVF
model because of its lethal phenotype. Nevertheless, the
haplodeﬁcient mice still provide a good indication of the
vascular remodeling process in elastin deﬁcient blood vessels.
In conclusion, in the present study it was shown that
elastin is a crucial factor in outward remodeling in murine
AVF. This study provides further evidence that interventions
aimed at the promotion of elastin degradation such as local
application of elastase could be a viable option to enhance
maturation of AVFs.
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